Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Soochow UniversityNo recent work listed

Lei Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9369-1132; OpenAlex author ID A5007148541. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper

Papers 4

  1. Retraction Note to: S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway. Last author DOI 10.1007/s00210-021-02126-x↗
  2. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway. Last author DOI 10.1007/s00210-019-01617-2↗
  3. A CARE-compliant case report: total pancreatectomy and total gastrectomy to treat pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/md.0000000000018151↗
  4. Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway. Co-author DOI 10.1002/cam4.1752↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Linxun Liu · 2 shared papers, 2019–2021 · strength 0.27
  2. Genhai Shen · 2 shared papers, 2019–2021 · strength 0.27
  3. Xiaofeng Xue · 2 shared papers, 2018–2019 · strength 0.18
  4. Yan Liu · 1 shared paper, 2021 · strength 0.16
  5. Yan Liu · 1 shared paper, 2019 · strength 0.11
  6. Yanghui Wen · 1 shared paper, 2019 · strength 0.10
  7. Xiaolan Xu · 1 shared paper, 2019 · strength 0.10
  8. Haixin Qian · 1 shared paper, 2019 · strength 0.10
  9. Ye Zhang · 1 shared paper, 2018 · strength 0.08
  10. Da‐Qing Yang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.